Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
NCT00003891
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
NETWORK
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
lurtotecan liposome
Sponsor
NCIC Clinical Trials Group
Collaborators
[object Object]